LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.

SEHK:2291 Stock Report

Market Cap: HK$8.0b

LEPU ScienTech Medical Technology (Shanghai) Future Growth

Future criteria checks 5/6

LEPU ScienTech Medical Technology (Shanghai) is forecast to grow earnings and revenue by 34.1% and 36.3% per annum respectively. EPS is expected to grow by 34.1% per annum. Return on equity is forecast to be 17.7% in 3 years.

Key information

34.1%

Earnings growth rate

34.1%

EPS growth rate

Medical Equipment earnings growth42.7%
Revenue growth rate36.3%
Future return on equity17.7%
Analyst coverage

Low

Last updated06 Mar 2025

Recent future growth updates

Recent updates

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

Apr 08
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

Returns On Capital Signal Tricky Times Ahead For LEPU ScienTech Medical Technology (Shanghai) (HKG:2291)

Oct 03
Returns On Capital Signal Tricky Times Ahead For LEPU ScienTech Medical Technology (Shanghai) (HKG:2291)

There's Reason For Concern Over LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Massive 36% Price Jump

Jul 03
There's Reason For Concern Over LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Massive 36% Price Jump

There Are Reasons To Feel Uneasy About LEPU ScienTech Medical Technology (Shanghai)'s (HKG:2291) Returns On Capital

Jun 09
There Are Reasons To Feel Uneasy About LEPU ScienTech Medical Technology (Shanghai)'s (HKG:2291) Returns On Capital

LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) May Have Issues Allocating Its Capital

Mar 03
LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) May Have Issues Allocating Its Capital

The Returns On Capital At LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) Don't Inspire Confidence

Nov 09
The Returns On Capital At LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) Don't Inspire Confidence

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Shareholders Might Be Looking For Exit

Aug 14
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Shareholders Might Be Looking For Exit

Earnings and Revenue Growth Forecasts

SEHK:2291 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026999499N/A4361
12/31/2025707370N/A3331
12/31/2024472246137222N/A
9/30/2024441231122214N/A
6/30/2024409216118206N/A
3/31/202436718498185N/A
12/31/202332715167164N/A
9/30/20233089132119N/A
6/30/202328932-275N/A
3/31/20232686-1070N/A
12/31/2022248-20-1866N/A
9/30/202224211-981N/A
6/30/202223641096N/A
3/31/2022230507101N/A
12/31/20212235913105N/A
12/31/2020148694359N/A
12/31/2019116523854N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2291's forecast earnings growth (34.1% per year) is above the savings rate (2.4%).

Earnings vs Market: 2291's earnings (34.1% per year) are forecast to grow faster than the Hong Kong market (10.5% per year).

High Growth Earnings: 2291's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 2291's revenue (36.3% per year) is forecast to grow faster than the Hong Kong market (8.2% per year).

High Growth Revenue: 2291's revenue (36.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 2291's Return on Equity is forecast to be low in 3 years time (17.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/30 17:33
End of Day Share Price 2025/04/30 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yuan GaoChina International Capital Corporation Limited